- Home
- ETV vs HROW Comparison
ETV vs HROW Comparison
Compare ETV & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETV
- HROW
- Stock Information
- Founded
- ETV 2005
- HROW 1998
- Country
- ETV United States
- HROW United States
- Employees
- ETV N/A
- HROW N/A
- Industry
- ETV Investment Managers
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- ETV Finance
- HROW Health Care
- Exchange
- ETV Nasdaq
- HROW Nasdaq
- Market Cap
- ETV 1.7B
- HROW 1.4B
- IPO Year
- ETV N/A
- HROW N/A
- Fundamental
- Price
- ETV $14.31
- HROW $42.00
- Analyst Decision
- ETV
- HROW Strong Buy
- Analyst Count
- ETV 0
- HROW 7
- Target Price
- ETV N/A
- HROW $68.50
- AVG Volume (30 Days)
- ETV 252.5K
- HROW 827.9K
- Earning Date
- ETV 01-01-0001
- HROW 11-12-2025
- Dividend Yield
- ETV 8.75%
- HROW N/A
- EPS Growth
- ETV N/A
- HROW N/A
- EPS
- ETV N/A
- HROW N/A
- Revenue
- ETV N/A
- HROW $227,661,000.00
- Revenue This Year
- ETV N/A
- HROW $43.92
- Revenue Next Year
- ETV N/A
- HROW $41.32
- P/E Ratio
- ETV N/A
- HROW N/A
- Revenue Growth
- ETV N/A
- HROW 47.69
- 52 Week Low
- ETV $11.05
- HROW $20.85
- 52 Week High
- ETV $13.50
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- ETV 63.22
- HROW 46.09
- Support Level
- ETV $14.06
- HROW $46.45
- Resistance Level
- ETV $14.32
- HROW $48.79
- Average True Range (ATR)
- ETV 0.13
- HROW 2.49
- MACD
- ETV 0.01
- HROW -0.72
- Stochastic Oscillator
- ETV 87.56
- HROW 14.10
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.